OTAOLA ARCA, HUGO

Preferred name

OTAOLA ARCA, HUGO

Main Affiliation

Facultad de Medicina Clínica Alemana Universidad del Desarrollo

ORCID

0000-0003-4952-2283

Scopus Author ID

57189385261, 57496672400

Goggle Scholar

https://scholar.google.com/citations?hl=es&user=subkKjQAAAAJ

Now showing 1 - 8 of 8

Some of the metrics are blocked by your
consent settings
Totally intracorporeal robot-assisted urinary diversion for bladder cancer (Part 1). Review and detailed characterization of ileal conduit and modified Indiana pouch
(2021)
Hugo Otaola-Arca
;
Rafael Coelho
;
Vipul R. Patel
;
Marcelo Orvieto
Scopus© Citations 1 1
Some of the metrics are blocked by your
consent settings
Impact of insufflator/aspirator versus exclusive insufflator during robotic radical prostatectomy: a comparative prospective cohort study
(2023)
Hugo Otaola-Arca
;
Orlando Mejías
;
Juan Cristóbal Bravo
;
Rodrigo Pinochet
;
Pablo Bernier
<jats:sec> <jats:title>Background:</jats:title> <jats:p>New generation devices that combine high-flow insufflation with smoke aspiration using continuous gas recirculation ]so-called Insufflator/aspirator systems (IAS)] have recently been developed to generate pneumoperitoneum. The use of an IAS could have an impact on surgical compared to conventional insufflation systems (CIS). The present study aimed to compare the clinical effectiveness/safety, healthorganizational, and pathological/oncological outcomes of the CIS versus IAS during robot-assisted radical prostatectomy (RARP).</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>Comparative retrospective cohort study including patients with non-metastatic prostate cancer treated with RARP by four expert surgeons at a robotic referral centre between January 2020 and December 2021. A CIS was used until 15 March 2021, and the IAS thereafter. Data were extracted from the Institutional Review Board-approved (#1064) retro and prospective institutional database.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>The final analysis included 299 patients (143 CIS; 156 IAS). We found no statistically significant differences in demographic data and preoperative results, allowing adequate group comparison. The rate of complications of any degree (9.1% and 1.9%, <jats:italic toggle="yes">P</jats:italic><0.05) and major complications (4.2% and 0.6%, <jats:italic toggle="yes">P</jats:italic><0.05) were lower in the IAS group. Accordingly, the hospital stay was shorter in the IAS group (<jats:italic toggle="yes">P</jats:italic><0.05); however, the small size of this statistically significant difference probably lacks clinical value (1.9±1.6 vs. 1.6±0.8 days). There was no significant difference in surgical time, bleeding, pathological findings, or oncological results.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>Data from this large group of patients showed that the rate of overall complications, the rate of major complications, and the length of stay were lower in the IAS group. Implementing the IAS in RARP patients increased the occurrence of SCE and affected our daily practice of transversus abdominis plane block. Interpretation of the results should be made with caution since the design of this study did not allow for the identification of a causal relationship.</jats:p> </jats:sec>
8Scopus© Citations 3
Some of the metrics are blocked by your
consent settings
The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review
(2024)
Yenny ARROYO-ROJAS
;
Lara RODRIGUEZ-SANCHEZ
;
Gianmarco COLANDREA
;
Hugo OTAOLA ARCA
;
Camille LANZ
1Scopus© Citations 3
Some of the metrics are blocked by your
consent settings
A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications
(2021)
Hugo Otaola-Arca
;
Manuel Álvarez-Ardura
;
Roberto Molina-Escudero
;
FERNANDEZ ARANCIBIA, MARIO
;
Álvaro Páez-Borda
Scopus© Citations 22 1
Some of the metrics are blocked by your
consent settings
Long-Term Oncological and Functional Outcomes After Robot-Assisted Partial Nephrectomy for Clinically Localized Renal Cell Carcinoma
(2022)
Hugo Otaola-Arca
;
Alfred Krebs
;
Hugo Bermúdez
;
Raúl Lyng
;
Marcelo Orvieto
Scopus© Citations 8 2
Some of the metrics are blocked by your
consent settings
Proper Use of the International Index of Erectile Function 5 (IIEF-5) Questionnaire in Patients Undergoing Transurethral Resection of the Prostate (TURP)
(2022)
Hugo Otaola-arca
;
Francisco Osorio Martini
;
Cabrera-Chamba, Adriana E
;
Nino-Taravilla, Carmen
9
Some of the metrics are blocked by your
consent settings
Successful extracorporeal membrane oxygenation therapy in a child with coronavirus 2019 disease-associated ARDS and chemotherapy for Ewing’s sarcoma
(2022)
Carmen Niño-Taravilla
;
Yuri Zuleta-Morales
;
Hugo Otaola-Arca
;
Benigno Montenegro
;
Cristian Sotomayor F
<jats:p> Most children and adolescents with SARS-CoV-2 infection show no or mild symptoms, but those with medical histories can be susceptible to more severe forms of disease. There are few reported cases of extracorporeal membrane oxygenation (ECMO) in pediatric patients with coronavirus disease 2019 (COVID-19). We present a previously healthy 13-year-old male diagnosed with metastatic Ewing’s sarcoma at the same time as catastrophic acute respiratory distress syndrome due to COVID-19, who was successfully supported by venovenous-ECMO while he received the corresponding chemotherapy protocol. </jats:p><jats:p> ECMO can be used as salvage therapy in oncology pediatric patients with respiratory failure secondary to COVID-19. In addition, successful chemotherapy can be administered while patients are supported on ECMO. </jats:p>
3
Some of the metrics are blocked by your
consent settings
Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab
(2020)
Carmen Niño-Taravilla
;
Yazmín P. Espinosa-Vielma
;
Hugo Otaola-Arca
;
POLI HARLOWE, MARIA CECILIA BERTA
;
Lorena I. Tapia
<jats:p>We describe a case of Pediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in an 8-year-old child. The patient developed multiorgan dysfunction, including mixed shock, cardiac dysfunction with myocarditis, pneumonia, acute kidney failure, and gastrointestinal involvement characterized by inflammation of the wall of the bowel and pancreatitis. After treatment with Tocilizumab and corticoid therapy, he presented clinical improvement and normalization of inflammatory markers. PIMS-TS is a new disease developed in a small percentage of patients, so a high degree of suspicion is necessary to establish the diagnosis. Supportive care is of paramount importance. The use of Tocilizumab to control the inflammatory response is likely to be beneficial, but the best immunotherapeutic agent has not yet been established. Randomized clinical studies should be run to determine the best treatment.</jats:p>
14Scopus© Citations 20

OTAOLA ARCA, HUGO

Filters

Settings

Sort By

Results per page